The Cutting Edge of TB Control: New Tools, New Strategies
05/15/12
(Complete Agenda with Session Objectives)
Jayne Ash Memorial Keynote: Three Months of Once-Weekly Rifapentine and Isoniazid for M. tuberculosis Infection: A Game Changer? Carol Dukes Hamilton, MD, MHS, FACP, FIDSA, Senior Scientist, Health & Development Sciences, FHI 360and Professor of Medicine, Duke University Medical Center
Plenary: Economic Considerations of Short-course LTBI Therapy : David Holland, MD, MHS, Assistant Professor of Medicine, Duke University Medical Center
CDPH TBCB Update: Pennan Barry, MD, MPH, Chief, Surveillance and Epidemiology Section, TB Control Branch (TBCB), California Department of Public Health (CDPH)
Breakouts Sessions
A. Implementation of the 3 HP Regimen in Program Settings
Crane, Jereb, Narita
1. Desmond, 2. Rivas, 3. Alexander
D. NAHPF– Business and Educational Session
1. CureTB, 2. TPAT
E. Cross BorderTB Issues and Challenges
1. Shah, 2. CureTB, 3. Kiy, 4. Laniado-Laborin